"ChEMBL ID";"Assay Type";"Description";"Organism";"Compounds";"Activities";"BAO Format ID";"BAO Format";"Confidence Score";"Confidence Label";"Strain";"Source";"Tax ID";"Tissue ChEMBL ID";"Tissue Name";"Cell Type";"Subcellular Fraction";"Document ChEMBL ID";"PubMed ID";"DOI";"Year";"Journal";"Volume";"First Page";"Last Page";"Assay Parameters";"Assay Classification L1";"Assay Classification L2";"Assay Classification L3";"Variant Sequence Accession";"Variant Sequence Mutation"
"CHEMBL1613997";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Kinetic Measurement of Intracellular Calcium Response. (Class of assay: confirmatory) ";"Rattus norvegicus";"673";"695";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"10116";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614216";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-001. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"206";"214";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614008";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP1-002 - Assay at 40 hr. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"142";"148";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1697722";"A";"Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset";"";"530";"544";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1697692";"20553011";"10.1021/tx1000865";"2010";"Chem Res Toxicol";"23";"1215";"1222";"";"";"";"";"";""
"CHEMBL1794584";"F";"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]";"";"63980";"64461";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909184";"B";"DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"9606";"";"";"Platelet";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909097";"B";"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)";"Sus scrofa";"871";"1742";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"9823";"CHEMBL3638187";"Heart";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613941";"F";"PUBCHEM_BIOASSAY: Validation screen for small molecules that induce DNA re-replication in MCF 10A normal breast cells. (Class of assay: confirmatory) ";"Homo sapiens";"308";"309";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614009";"F";"PUBCHEM_BIOASSAY: Cytometric Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells. (Class of assay: confirmatory) ";"Homo sapiens";"116";"116";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613805";"F";"PUBCHEM_BIOASSAY: Cytometry Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF cells. (Class of assay: confirmatory) ";"Homo sapiens";"270";"271";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"MEF";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1697779";"A";"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents";"Rodentia";"944";"951";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9989";"CHEMBL3559723";"Liver";"";"";"CHEMBL1697731";"20014752";"10.1021/tx900326k";"2010";"Chem Res Toxicol";"23";"171";"183";"";"";"";"";"";""
"CHEMBL1614670";"A";"Volume of distribution at steady state in human after iv administration";"Homo sapiens";"667";"669";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1614632";"18426954";"10.1124/dmd.108.020479";"2008";"Drug Metab Dispos";"36";"1385";"1405";"";"";"";"";"";""
"CHEMBL1613789";"F";"PUBCHEM_BIOASSAY: A small molecule screen for inhibitors of the PhoP region in Salmonella Typhimurium. (Class of assay: confirmatory) [Related pubchem assays: 2253, 1981, 1874 ]";"";"473";"476";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909130";"B";"DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Platelet";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909155";"B";"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"5";"5 - Multiple direct protein targets may be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638246";"Spinal cord";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909156";"B";"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909148";"B";"DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909206";"B";"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Insect cells";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909111";"B";"DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909089";"B";"DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909143";"B";"DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614072";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-014. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ";"Homo sapiens";"159";"166";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909214";"B";"DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909139";"B";"DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909162";"B";"DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)";"";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"U-937";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909168";"B";"DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909188";"B";"DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF)";"";"871";"1742";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"NIH3T3";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909192";"B";"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)";"Oryctolagus cuniculus";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9986";"CHEMBL3638235";"Lung";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909137";"B";"DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909112";"B";"DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909211";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909191";"B";"DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020)";"Bos taurus";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9913";"CHEMBL3638197";"Uterus";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909095";"B";"DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde)";"Rattus norvegicus";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"10116";"CHEMBL3638191";"Lens of camera-type eye";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909215";"B";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909129";"B";"DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"1321-N1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909177";"B";"DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"IMR-32";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613892";"F";"PUBCHEM_BIOASSAY: A screen for inhibitors of the PhoP region in Salmonella Typhi using a modified counterscreen. (Class of assay: confirmatory) ";"";"1023";"1028";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909181";"B";"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909131";"B";"DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Sf21";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909132";"B";"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909153";"B";"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909166";"B";"DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613995";"F";"PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature. (Class of assay: confirmatory) [Related pubchem assays: 902 ]";"Homo sapiens";"6267";"6303";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614310";"F";"PUBCHEM_BIOASSAY: Validation of Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ";"Homo sapiens";"280";"280";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1737902";"F";"PUBCHEM_BIOASSAY: qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485345, AID485355]";"";"75513";"75614";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909185";"B";"DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP)";"";"871";"1742";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"U-937";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909203";"B";"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Insect cells";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909183";"B";"DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu)";"Mus musculus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"ICR";"DrugMatrix";"10090";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909124";"B";"DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909136";"B";"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909121";"B";"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909098";"B";"DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat))";"Cavia porcellus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Dunkin-Hartley";"DrugMatrix";"10141";"CHEMBL3638251";"Adrenal gland";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909199";"B";"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909109";"B";"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909127";"B";"DRUGMATRIX: Chemokine CXCR1 (IL-8A)";"";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909135";"B";"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909141";"B";"DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614215";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-004. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"206";"215";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909171";"B";"DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909208";"B";"DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP)";"Oryctolagus cuniculus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"New Zealand albino";"DrugMatrix";"9986";"CHEMBL3638205";"Urinary bladder";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909209";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909101";"B";"DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon))";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"T47D";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1737980";"F";"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors: Validation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493163, AID504444, AID504648]";"Homo sapiens";"338";"338";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614530";"F";"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]";"Escherichia coli";"61607";"61711";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"562";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614086";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Agonists for Thrombopoietin (TPO) Signaling Pathway. (Class of assay: confirmatory) [Related pubchem assays: 918 ]";"Homo sapiens";"411";"417";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL965576";"B";"Inhibition of human brain MAOB";"Homo sapiens";"31";"31";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1152129";"18834112";"10.1021/jm800656v";"2008";"J Med Chem";"51";"6740";"6751";"";"";"";"";"";""
"CHEMBL958085";"F";"Antiproliferative activity against human 5637 cells after 96 hrs by crystal violet assay";"Homo sapiens";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"5637";"";"CHEMBL1150294";"18434163";"10.1016/j.bmc.2008.04.003";"2008";"Bioorg Med Chem";"16";"5570";"5583";"";"";"";"";"";""
"CHEMBL857778";"F";"Cross resistance profile versus L1210/R71 cells.";"Mus musculus";"21";"21";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1124835";"2362268";"10.1021/jm00169a014";"1990";"J Med Chem";"33";"1914";"1919";"";"";"";"";"";""
"CHEMBL1614168";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP1-002 - Assay at 24 hr. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"98";"103";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613813";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-022. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ";"Homo sapiens";"205";"215";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614404";"F";"PUBCHEM_BIOASSAY: Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 654 locus: Cytotoxicity. (Class of assay: confirmatory) ";"Homo sapiens";"13";"13";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL958086";"F";"Antiproliferative activity against human A427 cells after 96 hrs by crystal violet assay";"Homo sapiens";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A-427";"";"CHEMBL1150294";"18434163";"10.1016/j.bmc.2008.04.003";"2008";"Bioorg Med Chem";"16";"5570";"5583";"";"";"";"";"";""
"CHEMBL1613970";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Compounds that Induce Erasure of Genomic Imprints. (Class of assay: confirmatory) ";"";"5084";"5184";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614349";"F";"PUBCHEM_BIOASSAY: MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Dead Cells. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ";"Homo sapiens";"104";"111";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1794345";"F";"PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]";"Plasmodium falciparum";"170142";"170462";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"5833";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613876";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-005. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"229";"237";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1737868";"F";"PUBCHEM_BIOASSAY: Validation screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493143, AID504466]";"Homo sapiens";"244";"245";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909122";"B";"DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Chem-1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909138";"B";"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909170";"B";"DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909142";"B";"DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909119";"B";"DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HT-29";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909120";"B";"DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909105";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613964";"F";"PUBCHEM_BIOASSAY: MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Live Cells. (Class of assay: confirmatory) ";"Homo sapiens";"89";"94";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614492";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-008. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ";"Homo sapiens";"167";"175";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3137738";"T";"Comments (NB not yet translated). [column 'COMMENTAIRES' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137736";"T";"Animal toxicity known. [column 'TOXIC' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL1738606";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of GCN5L2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504398]";"Homo sapiens";"13828";"13960";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1697778";"A";"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans";"Homo sapiens";"944";"951";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL1697731";"20014752";"10.1021/tx900326k";"2010";"Chem Res Toxicol";"23";"171";"183";"";"";"";"";"";""
"CHEMBL3255794";"T";"Toxicity in mouse L1210 cells allografted CDF1 mouse assessed as change in body weight between day 1 and day 9 at 20 mg/kg, ip dosed on days 1, 5 and 9";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"CDF1";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244387";"74412";"10.1021/jm00200a012";"1978";"J Med Chem";"21";"204";"208";"standard_type:DOSE standard_relation:= standard_value:20.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL3562018";"F";"PubChem BioAssay. Immunotoxin (SS1P) sensitization/mitigation study - treatment arm.   (Class of assay: confirmatory) ";"";"401";"403";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613950";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-015. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"188";"196";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614211";"F";"PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ";"";"36499";"36798";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3137729";"T";"Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137727";"T";"Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137731";"T";"Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3562146";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 ratio channel.   (Class of assay: confirmatory) ";"";"1812";"1824";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL965574";"B";"Inhibition of human brain MAOA";"Homo sapiens";"32";"32";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1152129";"18834112";"10.1021/jm800656v";"2008";"J Med Chem";"51";"6740";"6751";"";"";"";"";"";""
"CHEMBL1738442";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404]";"Homo sapiens";"90360";"91293";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909176";"B";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"KAN-TS";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909161";"B";"DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta)";"";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"NIH3T3";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3039491";"A";"Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM";"Cricetulus griseus";"1878";"1881";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"10029";"";"";"CHO";"";"CHEMBL3039007";"23571415";"10.1124/mol.112.084152";"2013";"Mol Pharmacol";"83";"1257";"1267";"";"";"";"";"";""
"CHEMBL1909151";"B";"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613823";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Agonists for NFkB Signaling Pathway. (Class of assay: confirmatory) [Related pubchem assays: 895 ]";"Homo sapiens";"518";"532";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4296190";"F";"Antifungal activity against Cryptococcus neoformans H99 ATCC 208821 (CO-ADD:FG_002); MIC in YNB media using NBS plates, by Resazurin OD(600-570)";"Cryptococcus neoformans";"6133";"6235";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"ATCC 208821";"CO-ADD antimicrobial screening data";"5207";"";"";"";"";"CHEMBL4296181";"None";"10.6019/CHEMBL4296181";"None";"None";"None";"None";"None";"standard_type:ASSAY_TEST standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DETECTION_METHOD standard_relation:None standard_value:None standard_units:None comments:None | standard_type:MEDIA standard_relation:None standard_value:None standard_units:None comments:None | standard_type:PLATE_TYPE standard_relation:None standard_value:None standard_units:None comments:None | standard_type:TIME standard_relation:= standard_value:18.0 standard_units:hr comments:None";"";"";"";"";""
"CHEMBL4296185";"F";"Antibacterial activity against Escherichia coli ATCC 25922 (CO-ADD:GN_001); MIC in CAMBH media using NBS plates, by OD(600)";"Escherichia coli";"4585";"4681";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"ATCC 25922";"CO-ADD antimicrobial screening data";"562";"";"";"";"";"CHEMBL4296181";"None";"10.6019/CHEMBL4296181";"None";"None";"None";"None";"None";"standard_type:ASSAY_TEST standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DETECTION_METHOD standard_relation:None standard_value:None standard_units:None comments:None | standard_type:MEDIA standard_relation:None standard_value:None standard_units:None comments:None | standard_type:PLATE_TYPE standard_relation:None standard_value:None standard_units:None comments:None | standard_type:TIME standard_relation:= standard_value:18.0 standard_units:hr comments:None";"";"";"";"";""
"CHEMBL4296184";"F";"Antibacterial activity against Staphylococcus aureus MRSA ATCC 43300 (CO-ADD:GP_020); MIC in CAMBH media, using NBS plates, by OD(600)";"Staphylococcus aureus subsp. aureus";"4588";"4684";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"ATCC 43300";"CO-ADD antimicrobial screening data";"46170";"";"";"";"";"CHEMBL4296181";"None";"10.6019/CHEMBL4296181";"None";"None";"None";"None";"None";"standard_type:ASSAY_TEST standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DETECTION_METHOD standard_relation:None standard_value:None standard_units:None comments:None | standard_type:MEDIA standard_relation:None standard_value:None standard_units:None comments:None | standard_type:PLATE_TYPE standard_relation:None standard_value:None standard_units:None comments:None | standard_type:TIME standard_relation:= standard_value:18.0 standard_units:hr comments:None";"";"";"";"";""
"CHEMBL1614097";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-024. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ";"Homo sapiens";"200";"208";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909108";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HeLa";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909092";"B";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909172";"B";"DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909179";"B";"DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909198";"B";"DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Sf9";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909102";"B";"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909154";"B";"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909194";"B";"DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Neutrophil";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614218";"F";"PUBCHEM_BIOASSAY: MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Dead Cells. (Class of assay: confirmatory) ";"";"267";"274";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909117";"B";"DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha)";"";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"U-937";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909096";"B";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909099";"B";"DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin)";"Bacillus cereus";"871";"1742";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"1396";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909213";"B";"DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3562038";"F";"PubChem BioAssay. SNU-C1 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ";"";"229";"230";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"SNU-C1";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3214990";"F";"PubChem BioAssay. qHTS profiling for inhibitors of Plasmodium falciparum (3D7) proliferation.   (Class of assay: confirmatory) ";"";"256";"262";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3284438";"F";"Antitumor activity against mouse L1210 cells allografted in po dosed mouse assessed as dose required for minimal activity administered qd from day 1 to day 9 post tumor implantation";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL981353";"F";"Antiproliferative activity against mouse P388 cells at 0.01 ug after 48 hrs by two-layer agar-diffusion method";"Mus musculus";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1147285";"2778449";"10.1021/np50063a010";"1989";"J Nat Prod";"52";"522";"527";"";"";"";"";"";""
"CHEMBL3562152";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen2, ratio channel.   (Class of assay: confirmatory) ";"";"1822";"1837";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL958088";"F";"Antiproliferative activity against human MCF7 cells after 96 hrs by crystal violet assay";"Homo sapiens";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1150294";"18434163";"10.1016/j.bmc.2008.04.003";"2008";"Bioorg Med Chem";"16";"5570";"5583";"";"";"";"";"";""
"CHEMBL1614458";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))]";"Homo sapiens";"75376";"75927";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3284160";"F";"Antitumor activity against mouse L1210 cells allografted in ip dosed mouse assessed as increase in life span at optimal dose administered qd from day 1 to day 9 post tumor implantation relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3284720";"F";"Cytotoxicity against mouse L1210 cells assessed as cessation of growth in presence of cytidine";"Mus musculus";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"";"";"";"";""
"CHEMBL4029349";"T";"Liver toxicity in human assessed as induction of drug-induced liver injury by measuring severity class index";"Homo sapiens";"929";"929";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4028802";"26948801";"10.1016/j.drudis.2016.02.015";"2016";"Drug Discov Today";"21";"648";"653";"";"";"";"";"";""
"CHEMBL1614522";"F";"PUBCHEM_BIOASSAY: qHTS Validation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM). (Class of assay: confirmatory) [Related pubchem assays: 593 (Fluorescein region spectral profiling screen), 594 (Rhodamine region spectral profiling screen)]";"Homo sapiens";"777";"781";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3284464";"A";"Therapeutic index, ratio of toxicity in ip dosed mouse allografted with mouse L1210 cells assessed as optimal dose required for maximum increase in life span to antitumor activity against mouse L1210 cells allografted in ip dosed mouse assessed as lowest dose required for 40% increase in life span";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"";"";"";"";""
"CHEMBL981349";"F";"Antiproliferative activity against human HT-29 cells at 0.01 ug after 48 hrs by two-layer agar-diffusion method";"Homo sapiens";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1147285";"2778449";"10.1021/np50063a010";"1989";"J Nat Prod";"52";"522";"527";"";"";"";"";"";""
"CHEMBL3802577";"F";"Antiviral activity against VSV-G pseudotyped HIV-1 NL4-3 infected in human U373-MAGI cells assessed as Pol mutation at 260 uM incubated for 2 hrs prior to infection measured at 72 hrs post infection by illumina sequencing method (Rvb = 18.5%)";"Human immunodeficiency virus 1";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"NL4-3";"Scientific Literature";"11676";"";"";"U373-MAGI";"";"CHEMBL3797079";"27117260";"10.1016/j.bmc.2016.03.052";"2016";"Bioorg Med Chem";"24";"2410";"2422";"";"";"";"";"";""
"CHEMBL1613785";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-010. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ";"Homo sapiens";"227";"237";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613791";"F";"PUBCHEM_BIOASSAY: A counter screen for small molecule screen for inhibitors of the PhoP region in Salmonella typhi. (Class of assay: confirmatory) [Related pubchem assays: 1850, 1864, 2252, 1985 ]";"";"1121";"1126";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614267";"F";"PUBCHEM_BIOASSAY: MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Dead Cells. (Class of assay: confirmatory) ";"";"120";"127";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613967";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-020. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ";"Homo sapiens";"178";"186";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL706081";"F";"Compound was tested for its inhibitory activity against L1210 lymphoid leukemia";"Mus musculus";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1123674";"3806615";"10.1021/jm00385a016";"1987";"J Med Chem";"30";"340";"347";"";"";"";"";"";""
"CHEMBL981352";"F";"Antiproliferative activity against mouse P388 cells at 0.1 ug after 48 hrs by two-layer agar-diffusion method";"Mus musculus";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1147285";"2778449";"10.1021/np50063a010";"1989";"J Nat Prod";"52";"522";"527";"";"";"";"";"";""
"CHEMBL1738675";"F";"PUBCHEM_BIOASSAY: Validation screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493125, AID504467]";"Homo sapiens";"366";"366";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614092";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-019. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"185";"194";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1794524";"F";"PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling. (Class of assay: confirmatory) ";"";"384";"429";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3284163";"F";"Antitumor activity against mouse L1210 cells allografted in ip dosed mouse assessed as increase in life span at optimal dose administered qd from day 1 to day 9 post intracerebral tumor implantation relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL1738588";"F";"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]";"Homo sapiens";"94040";"94083";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1794321";"F";"PUBCHEM_BIOASSAY: qHTS assay for small molecule agonists of androgen receptor signaling. (Class of assay: confirmatory) ";"";"368";"400";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614034";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Antagonists for Thrombopoietin (TPO) Signaling Pathway. (Class of assay: confirmatory) [Related pubchem assays: 917 ]";"Homo sapiens";"411";"417";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614067";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM). (Class of assay: confirmatory) [Related pubchem assays: 593 (Fluorescein region spectral profiling screen), 2386 (Probe Development Summary for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 594 (Rhodamine region spectral profiling screen), 2364 (qHTS Validation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM))]";"Homo sapiens";"2514";"2577";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909134";"B";"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909086";"B";"DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"9";"9 - Direct single protein target assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559723";"Liver";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909118";"B";"DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HUVEC";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614673";"A";"Mean residence time in human after iv administration";"Homo sapiens";"667";"669";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1614632";"18426954";"10.1124/dmd.108.020479";"2008";"Drug Metab Dispos";"36";"1385";"1405";"";"";"";"";"";""
"CHEMBL1614674";"A";"Half life in human after iv administration";"Homo sapiens";"667";"669";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1614632";"18426954";"10.1124/dmd.108.020479";"2008";"Drug Metab Dispos";"36";"1385";"1405";"";"";"";"";"";""
"CHEMBL1909190";"B";"DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909158";"B";"DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909114";"B";"DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909174";"B";"DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909196";"B";"DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"Rheumatoid synovial fibroblasts";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909090";"B";"DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Sf9";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613923";"F";"PUBCHEM_BIOASSAY: A cytotoxicity screen of small molecule inhibitors of the PhoP region in Salmonella typhi identified in the primary screen. (Class of assay: confirmatory) [Related pubchem assays: 1850, 1864, 1985 ]";"";"1504";"1509";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909128";"B";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2114788";"F";"PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ";"Homo sapiens";"103470";"103901";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2114797";"F";"PubChem BioAssay. qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway. (Class of assay: confirmatory) ";"Rattus norvegicus";"424";"495";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"10116";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4020295";"T";"Toxicity in iv dosed NOD.SCID mouse xenografted with gamma-irradiated human Kasumi-1 cells administered as qd for every 7 days";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL4017535";"28949521";"10.1021/acs.jmedchem.7b00746";"2017";"J Med Chem";"60";"8369";"8384";"";"ALIMENTARY TRACT AND METABOLISM | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Genetically Diabetic Animals | Methods for Testing Immunological Factors";"Spontaneously Diabetic Mice: KK Mouse, KK-AY Mouse, NOD Mouse, Obese Hyperglycemic Mice, Diabetic db/db Mice, Diabetes Obesity Syndrome in CBA/Ca Mice, Wellesley Mouse | Spontaneous Autoimmune Diseases In Animals";"";""
"CHEMBL1738317";"F";"PUBCHEM_BIOASSAY: qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493106, AID493143]";"Homo sapiens";"24903";"24918";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613904";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-026. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"146";"154";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1794293";"F";"PUBCHEM_BIOASSAY: qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling. (Class of assay: confirmatory) ";"";"302";"330";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2114803";"F";"PubChem BioAssay. Cell Proliferation Assay against the TMD8 Cell Line (Caspase readout at 8 hrs). (Class of assay: confirmatory) ";"";"226";"228";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614356";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-017. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"181";"191";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614362";"F";"PUBCHEM_BIOASSAY: Validation screen for inhibitors of Lassa infection. (Class of assay: confirmatory) ";"";"263";"264";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614393";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-012. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ";"Homo sapiens";"186";"194";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613853";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-016. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ";"Homo sapiens";"147";"156";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613838";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) ";"Homo sapiens";"21944";"21990";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2114835";"F";"PubChem BioAssay. qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion. (Class of assay: confirmatory) ";"Homo sapiens";"321";"329";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613947";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-009. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"182";"191";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3285525";"F";"Antitumor activity against mouse L1210 cells allografted in ip dosed mouse assessed as change in body weight at optimal dose administered qd on day 1 post tumor implantation measured on day 5 relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3285520";"F";"Antitumor activity against mouse L1210 cells allografted in ip dosed mouse assessed as change in body weight at optimal dose administered qd from day 1 to day 9 post intracerebral tumor implantation measured on day 5 relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3257010";"T";"Toxicity in CDF1 mouse assessed as change in body weight at 6.25 mg/kg, ip measured on day 5 relative to control";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"CDF1";"Scientific Literature";"10090";"";"";"";"";"CHEMBL3244095";"92567";"10.1021/jm00196a015";"1979";"J Med Chem";"22";"1230";"1234";"standard_type:DOSE standard_relation:= standard_value:6.25 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL1697780";"A";"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents";"";"944";"951";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1697731";"20014752";"10.1021/tx900326k";"2010";"Chem Res Toxicol";"23";"171";"183";"";"";"";"";"";""
"CHEMBL958087";"F";"Antiproliferative activity against human KYSE70 cells after 96 hrs by crystal violet assay";"Homo sapiens";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KYSE-70 cell line";"";"CHEMBL1150294";"18434163";"10.1016/j.bmc.2008.04.003";"2008";"Bioorg Med Chem";"16";"5570";"5583";"";"";"";"";"";""
"CHEMBL1613942";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-006. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ";"Homo sapiens";"166";"173";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909323";"A";"Drug Induced Liver Injury Prediction System (DILIps) validation dataset; compound DILI positive/negative as observed in Pfizer data";"";"148";"148";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL2114784";"F";"PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ";"Homo sapiens";"53812";"54032";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909087";"B";"DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909160";"B";"DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"9";"9 - Direct single protein target assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559723";"Liver";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909180";"B";"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909100";"B";"DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Chem-1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909106";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630)";"";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909200";"B";"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909104";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909197";"B";"DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909201";"B";"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614049";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-007. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ";"Homo sapiens";"178";"186";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614671";"A";"Clearance in human after iv administration";"Homo sapiens";"667";"669";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1614632";"18426954";"10.1124/dmd.108.020479";"2008";"Drug Metab Dispos";"36";"1385";"1405";"";"";"";"";"";""
"CHEMBL1909210";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"9";"9 - Direct single protein target assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909202";"B";"DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909150";"B";"DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HeLa S3";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909152";"B";"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613919";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP1-002 - Assay at 16 hr. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"98";"103";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3214913";"B";"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Marburg Virus.   (Class of assay: confirmatory) ";"";"4591";"5133";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3562085";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, ratio channel.   (Class of assay: confirmatory) ";"";"558";"558";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1794560";"F";"PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of androgen receptor signaling. (Class of assay: confirmatory) ";"";"447";"493";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1738552";"F";"PUBCHEM_BIOASSAY: Dose Response selectivity of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a 697B cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435012, AID465]";"";"693";"694";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1738369";"F";"PUBCHEM_BIOASSAY: Dose response confirmation of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a Jurkat cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435012, AID465]";"";"693";"694";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"Jurkat";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614486";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-023. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"140";"146";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2114730";"F";"PubChem BioAssay. Cell Proliferation Assay against the TMD8 Cell Line (Caspase readout at 16 hrs). (Class of assay: confirmatory) ";"";"270";"272";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2114777";"F";"PubChem BioAssay. Cell Proliferation Assay against a hMSC Cell Line. (Class of assay: confirmatory) ";"";"271";"272";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3255796";"T";"Toxicity in mouse L1210 cells allografted CDF1 mouse assessed as change in body weight between day 1 and day 9 at 5 mg/kg, ip dosed on days 1, 5 and 9";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"CDF1";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244387";"74412";"10.1021/jm00200a012";"1978";"J Med Chem";"21";"204";"208";"standard_type:DOSE standard_relation:= standard_value:5.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL1614528";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-018. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ";"Homo sapiens";"171";"180";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909204";"B";"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Insect cells";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909147";"B";"DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909144";"B";"DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4005423";"F";"Antiproliferative activity against human SKM1-S cells after 48 hrs by XTT assay";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"SKM1-S";"";"CHEMBL4004814";"28094938";"10.1021/acs.jmedchem.6b01803";"2017";"J Med Chem";"60";"1523";"1533";"";"";"";"";"";""
"CHEMBL1794364";"F";"PUBCHEM_BIOASSAY: qHTS assay for small molecule agonists of estrogen receptor alpha signaling. (Class of assay: confirmatory) ";"";"346";"396";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1794380";"F";"PUBCHEM_BIOASSAY: qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588378, AID588380]";"Homo sapiens";"326";"327";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"SH-SY5Y";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1794401";"F";"PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962]";"";"91505";"91819";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614279";"F";"PUBCHEM_BIOASSAY: qHTS Validation Assay to Find Inhibitors of T. brucei phosphofructokinase. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488768, AID492961]";"Trypanosoma brucei";"648";"649";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"185431";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614274";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Antagonists for NFkB Signaling Pathway. (Class of assay: confirmatory) ";"Homo sapiens";"518";"532";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1738312";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391]";"Homo sapiens";"55525";"55724";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614231";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-002. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ";"Homo sapiens";"143";"150";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2114890";"F";"PubChem BioAssay. qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway. (Class of assay: confirmatory) ";"Homo sapiens";"1142";"1339";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614015";"F";"PUBCHEM_BIOASSAY: qHTS Validation Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493014]";"Homo sapiens";"304";"304";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614477";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-011. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ";"Homo sapiens";"161";"170";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1964081";"F";"PUBCHEM_BIOASSAY: S16 Schwann cell PMP22 intronic element firefly luciferase assay. (Class of assay: confirmatory) ";"";"1025";"1028";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"Schwann";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3285515";"F";"Antitumor activity against mouse L1210 cells allografted in ip dosed mouse assessed as change in body weight at optimal dose administered qd from day 1 to day 9 post tumor implantation measured on day 5 relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL1614293";"F";"PUBCHEM_BIOASSAY: High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF Cells. (Class of assay: confirmatory) ";"Homo sapiens";"176";"176";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1794308";"F";"PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]";"Homo sapiens";"61908";"62243";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"HEK293";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614544";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ";"Homo sapiens";"36150";"36356";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909116";"B";"DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Platelet";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909140";"B";"DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909207";"B";"DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613890";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-003. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"151";"159";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909189";"B";"DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide)";"";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"HIT-T15";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614518";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-025. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"133";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3255790";"T";"Toxicity in mouse L1210 cells allografted CDF1 mouse assessed as change in body weight between day 1 and day 5 at 10 mg/kg, ip dosed on days 1 and 5";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"CDF1";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244387";"74412";"10.1021/jm00200a012";"1978";"J Med Chem";"21";"204";"208";"standard_type:DOSE standard_relation:= standard_value:10.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL3039488";"A";"Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM";"Cricetulus griseus";"1862";"1865";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"10029";"";"";"CHO";"";"CHEMBL3039007";"23571415";"10.1124/mol.112.084152";"2013";"Mol Pharmacol";"83";"1257";"1267";"";"";"";"";"";""
"CHEMBL1697730";"A";"Human drug-induced liver injury (DILI) modelling dataset from Ekins et al";"Homo sapiens";"529";"532";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL1697723";"20843939";"10.1124/dmd.110.035113";"2010";"Drug Metab Dispos";"38";"2302";"2308";"";"";"";"";"";""
"CHEMBL1909091";"B";"DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909187";"B";"DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Platelet";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909103";"B";"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909123";"B";"DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA))";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Erythrocyte";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909157";"B";"DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909167";"B";"DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909175";"B";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"SK-N-MC";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1794512";"F";"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Cell Surface uPA Generation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493178]";"";"12416";"12428";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614132";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-021. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"179";"188";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614127";"F";"PUBCHEM_BIOASSAY: A screen for inhibitors of the PhoP region in Salmonella Typhimurium using a modified counterscreen. (Class of assay: confirmatory) [Related pubchem assays: 2253, 1863, 1874 ]";"";"480";"483";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4029350";"T";"Liver toxicity in human assessed as induction of drug-induced liver injury by measuring verified drug-induced liver injury concern status";"Homo sapiens";"929";"929";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4028802";"26948801";"10.1016/j.drudis.2016.02.015";"2016";"Drug Discov Today";"21";"648";"653";"";"";"";"";"";""
"CHEMBL1614455";"F";"PUBCHEM_BIOASSAY: A Counter Screen to identiry small molecule screen for inhibitors of the PhoP region in Salmonella Typhimurium. (Class of assay: confirmatory) [Related pubchem assays: 2253, 1863, 1981, 1874 ]";"";"529";"532";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614100";"F";"PUBCHEM_BIOASSAY: A small molecule screen for inhibitors of the PhoP region in Salmonella typhi. (Class of assay: confirmatory) [Related pubchem assays: 1864, 2252, 1985 ]";"";"1016";"1021";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614425";"F";"PUBCHEM_BIOASSAY: MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Live Cells. (Class of assay: confirmatory) ";"Homo sapiens";"216";"222";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2320306";"B";"Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay";"Homo sapiens";"62";"62";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"HEK293";"";"CHEMBL2311273";"23241029";"10.1021/jm301302s";"2013";"J Med Chem";"56";"781";"795";"";"";"";"";"";""
"CHEMBL1614329";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP1-003 - Assay at 40 hr. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"176";"182";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1738636";"F";"PUBCHEM_BIOASSAY: Validation screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463097, AID463113, AID493165, AID493166, AID504806, AID504809]";"Homo sapiens";"129";"129";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"SW480";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3562088";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, green channel.   (Class of assay: confirmatory) ";"";"570";"570";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3562112";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, blue channel.   (Class of assay: confirmatory) ";"";"556";"556";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3284444";"T";"Toxicity in ip dosed mouse allografted with mouse L1210 cells assessed as dose required for optimal activity administered every 6 hrs on day 1, 5 and 9 post tumor implantation";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3284453";"F";"Antitumor activity against mouse L1210 cells allografted in ip dosed mouse assessed as dose required for maximal activity administered every 6 hrs on day 1, 5 and 9 post tumor implantation";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3284718";"A";"Therapeutic index, ratio of toxicity in ip dosed mouse allografted with mouse L1210 cells assessed as highest dose required for 40% increase in life span to antitumor activity against mouse L1210 cells allografted in ip dosed mouse assessed as lowest dose required for 40% increase in life span";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"";"";"";"";""
"CHEMBL3284719";"F";"Cytotoxicity against mouse L1210 cells assessed as cessation of growth";"Mus musculus";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"";"";"";"";""
"CHEMBL3562133";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen1 green channel.   (Class of assay: confirmatory) ";"";"570";"570";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614263";"F";"PUBCHEM_BIOASSAY: Quantitative High-Throughput Screen for Regulators of Epigenetic Control. (Class of assay: confirmatory) [Related pubchem assays: 1041, 1039, 890, 1036, 1653, 1035, 1043, 1038, 990, 597, 1042, 1037 ]";"";"5529";"5572";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3562069";"F";"PubChem BioAssay. Colo320 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ";"";"233";"234";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3284166";"F";"Antitumor activity against mouse L1210 cells allografted in ip dosed mouse assessed as dose required for minimal activity administered qd on day 1 post tumor implantation";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3285524";"F";"Antitumor activity against mouse L1210 cells allografted in ip dosed mouse assessed as change in body weight at optimal dose administered qd on day 1, 5 and 9 post tumor implantation measured on day 5 relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL1614435";"F";"PUBCHEM_BIOASSAY: MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Live Cells. (Class of assay: confirmatory) ";"Homo sapiens";"86";"93";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1737994";"F";"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504444]";"";"15530";"15589";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL943089";"P";"Partition coefficient, log P of the compound";"";"67";"67";"BAO_0000100";"small-molecule physicochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1140694";"18027916";"10.1021/jm070524a";"2008";"J Med Chem";"51";"219";"237";"";"";"";"";"";""
"CHEMBL1909133";"B";"DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909085";"B";"DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"9";"9 - Direct single protein target assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3987361";"Submaxillary gland";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614053";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-013. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"166";"174";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909205";"B";"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Insect cells";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909186";"B";"DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Platelet";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2114909";"F";"PubChem BioAssay. HTS assay for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1: Hit Confirmation. (Class of assay: confirmatory) ";"Homo sapiens";"621";"621";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL650218";"F";"Beta-blocking activity measured by applying the stepwise linear discriminate analysis; Inactive";"";"48";"48";"BAO_0000019";"assay format";"4";"4 - Multiple homologous protein targets may be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1129855";"None";"10.1016/S0960-894X(97)00046-2";"1997";"Bioorg Med Chem Lett";"7";"567";"572";"";"";"";"";"";""
"CHEMBL3802571";"F";"Antiviral activity against VSV-G pseudotyped HIV-1 NL4-3 infected in human U373-MAGI cells assessed as reduction in U5-gag level at 25 to 400 uM after 2 to 72 hrs by qPCR method";"Human immunodeficiency virus 1";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"NL4-3";"Scientific Literature";"11676";"";"";"U373-MAGI";"";"CHEMBL3797079";"27117260";"10.1016/j.bmc.2016.03.052";"2016";"Bioorg Med Chem";"24";"2410";"2422";"";"";"";"";"";""
"CHEMBL3256220";"A";"Half life in rat";"Rattus norvegicus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"";"";"CHEMBL3244387";"74412";"10.1021/jm00200a012";"1978";"J Med Chem";"21";"204";"208";"";"";"";"";"";""
"CHEMBL1614292";"F";"PUBCHEM_BIOASSAY: qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488768, AID492961]";"Trypanosoma brucei TREU927";"5071";"5076";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"185431";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1794553";"F";"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860]";"Homo sapiens";"58172";"58459";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"HepG2";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614171";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Human Peripheral Myelin Protein 22 (PMP22) Expression/Activity. (Class of assay: confirmatory) ";"Homo sapiens";"696";"699";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1794542";"F";"PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of estrogen receptor alpha signaling. (Class of assay: confirmatory) ";"";"378";"432";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3257012";"T";"Toxicity in CDF1 mouse assessed as change in body weight at 3.12 mg/kg, ip measured on day 5 relative to control";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"CDF1";"Scientific Literature";"10090";"";"";"";"";"CHEMBL3244095";"92567";"10.1021/jm00196a015";"1979";"J Med Chem";"22";"1230";"1234";"standard_type:DOSE standard_relation:= standard_value:3.12 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL1614312";"F";"PUBCHEM_BIOASSAY: A cytotoxicity screen of small molecule inhibitors of the PhoP region in Salmonella Typhimurium identified in the primary screen. (Class of assay: confirmatory) [Related pubchem assays: 1863, 1981, 1874 ]";"";"1307";"1310";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909193";"B";"DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909173";"B";"DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909182";"B";"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909107";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808)";"Cavia porcellus";"871";"1742";"BAO_0000249";"cell membrane format";"9";"9 - Direct single protein target assigned";"Dunkin-Hartley";"DrugMatrix";"10141";"CHEMBL3638255";"Striatum";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909084";"B";"DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine)";"Cavia porcellus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Dunkin-Hartley";"DrugMatrix";"10141";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909088";"B";"DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Sf9";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909115";"B";"DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone)";"Escherichia coli";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909126";"B";"DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909146";"B";"DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Sf9";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909164";"B";"DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909110";"B";"DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Jurkat";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909113";"B";"DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909094";"B";"DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"MDCK";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909149";"B";"DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1737912";"F";"PUBCHEM_BIOASSAY: Dose response counterscreen of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a HEK-293T cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435012, AID489026]";"";"693";"694";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"HEK-293T";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1738494";"F";"PUBCHEM_BIOASSAY: Dose response cytotoxicity of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a HEK-293T cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435012, AID489041]";"";"693";"694";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"HEK-293T";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3284439";"F";"Antitumor activity against mouse L1210 cells allografted in ip dosed mouse assessed as dose required for minimal activity administered qd from day 1 to day 9 post intracerebral tumor implantation";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3284457";"F";"Antitumor activity against mouse P388 cells allografted in ip dosed mouse assessed as dose required for maximal activity administered qd from day 1 to day 9 post tumor implantation";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL1909178";"B";"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)";"Rattus norvegicus";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"10116";"CHEMBL3638233";"Cerebellum";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909145";"B";"DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Sf9";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909159";"B";"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3256550";"F";"Antitumor activity in mouse L1210 cells allografted in CDF1 mouse assessed as increase in life span at 6.25 mg/kg, ip administered as qd for 9 days relative to control";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244095";"92567";"10.1021/jm00196a015";"1979";"J Med Chem";"22";"1230";"1234";"standard_type:DOSE standard_relation:= standard_value:6.25 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL4296187";"F";"Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 (CO-ADD:GN_042); MIC in CAMBH media using NBS plates, by OD(600)";"Pseudomonas aeruginosa";"24161";"24267";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"ATCC 27853";"CO-ADD antimicrobial screening data";"287";"";"";"";"";"CHEMBL4296181";"None";"10.6019/CHEMBL4296181";"None";"None";"None";"None";"None";"standard_type:ASSAY_TEST standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DETECTION_METHOD standard_relation:None standard_value:None standard_units:None comments:None | standard_type:MEDIA standard_relation:None standard_value:None standard_units:None comments:None | standard_type:PLATE_TYPE standard_relation:None standard_value:None standard_units:None comments:None | standard_type:TIME standard_relation:= standard_value:18.0 standard_units:hr comments:None";"";"";"";"";""
"CHEMBL3284161";"F";"Antitumor activity against 5-azacytidine-resistant mouse L1210 cells allografted in ip dosed mouse assessed as increase in life span at optimal dose administered qd from day 1 to day 9 post tumor implantation relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3284447";"T";"Toxicity in po dosed mouse allografted with mouse L1210 cells assessed as dose required for optimal activity administered qd from day 1 to day 9 post tumor implantation";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL1794375";"B";"PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]";"";"83389";"88483";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1794367";"F";"PUBCHEM_BIOASSAY: qHTS for Inhibitors of ATXN expression: Validation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588349, AID588380]";"";"376";"378";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3215185";"F";"PubChem BioAssay. qHTS screen for enhancers of Arylsulfatase A (ASA1): LOPAC Validation Assay.   (Class of assay: confirmatory) ";"";"651";"652";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2114780";"F";"PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ";"Homo sapiens";"58729";"58906";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"SW480";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3284162";"F";"Antitumor activity against mouse L1210 cells allografted in po dosed mouse assessed as increase in life span at optimal dose administered qd from day 1 to day 9 post tumor implantation relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3284721";"F";"Cytotoxicity against mouse L1210 cells assessed as cessation of growth in presence of uridine";"Mus musculus";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"";"";"";"";""
"CHEMBL2114929";"F";"PubChem BioAssay. qHTS screen for small molecules that inhibit ELG1-dependent DNA repair: Hit Confirmation with Unstimulated Viability Assay. (Class of assay: confirmatory) ";"Homo sapiens";"477";"488";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3214892";"F";"PubChem BioAssay. qHTS profiling for inhibitors of Plasmodium falciparum (DD2) proliferation.   (Class of assay: confirmatory) ";"";"244";"249";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2114872";"F";"PubChem BioAssay. qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1: Hit Confirmation using MMS Stimulated ELG1. (Class of assay: confirmatory) ";"Homo sapiens";"534";"534";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2114775";"F";"PubChem BioAssay. qHTS Assay for Inhibitors of Hepatitis C Virus (HCV). (Class of assay: confirmatory) ";"";"75093";"75549";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2114843";"F";"PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ";"Homo sapiens";"68426";"68635";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2114770";"F";"PubChem BioAssay. qHTS Assay for Identification of Small Molecule Antagonists for NFkB Signaling Pathway. (Class of assay: confirmatory) ";"";"267";"269";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909165";"B";"DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid)";"Oryctolagus cuniculus";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9986";"";"";"Reticulocytes";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909212";"B";"DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909125";"B";"DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Chem-1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909163";"B";"DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4)";"Cavia porcellus";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"10141";"CHEMBL3638235";"Lung";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909169";"B";"DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909195";"B";"DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Neutrophil";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614036";"F";"PUBCHEM_BIOASSAY: Cell Viability - LYMP1-003 - Assay at 24 hr. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ";"Homo sapiens";"96";"101";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"Lymphoblastoid cell";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909093";"B";"DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL981345";"F";"Antiproliferative activity against human HT-29 cells after 96 hrs by MTT assay";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1147285";"2778449";"10.1021/np50063a010";"1989";"J Nat Prod";"52";"522";"527";"";"";"";"";"";""
"CHEMBL981347";"F";"Antiproliferative activity against human HT-29 cells at 1 ug after 48 hrs by two-layer agar-diffusion method";"Homo sapiens";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1147285";"2778449";"10.1021/np50063a010";"1989";"J Nat Prod";"52";"522";"527";"";"";"";"";"";""
"CHEMBL981348";"F";"Antiproliferative activity against human HT-29 cells at 0.1 ug after 48 hrs by two-layer agar-diffusion method";"Homo sapiens";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1147285";"2778449";"10.1021/np50063a010";"1989";"J Nat Prod";"52";"522";"527";"";"";"";"";"";""
"CHEMBL1794371";"F";"PUBCHEM_BIOASSAY: qHTS assay for small molecule agonists of retinoid X receptor alpha signaling. (Class of assay: confirmatory) ";"";"423";"480";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613918";"F";"PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ]";"Homo sapiens";"18608";"18631";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL635477";"P";"Partition coefficient (logD7.4)";"";"61";"66";"BAO_0000100";"small-molecule physicochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1124835";"2362268";"10.1021/jm00169a014";"1990";"J Med Chem";"33";"1914";"1919";"";"";"";"";"";""
"CHEMBL2114861";"F";"PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen. (Class of assay: confirmatory) ";"";"26907";"26955";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2114895";"F";"PubChem BioAssay. qHTS assay for small molecule activators of the p53 signaling pathway. (Class of assay: confirmatory) ";"Homo sapiens";"263";"303";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2114779";"F";"PubChem BioAssay. Cytotoxicity counterscreen for NFkB agonists and antagonists. (Class of assay: confirmatory) ";"";"224";"226";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2354311";"F";"PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ";"";"31581";"31649";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4296191";"F";"Cytotoxicity against HEK293 cells (CO-ADD:MA_007); CC50 by cell viability assay in DMEM (10% FBS) media using TC plates, by Resazurin F(560/590)";"Homo sapiens";"899";"919";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"ATCC CRL1573";"CO-ADD antimicrobial screening data";"9606";"";"";"HEK293";"";"CHEMBL4296181";"None";"10.6019/CHEMBL4296181";"None";"None";"None";"None";"None";"standard_type:ASSAY_TEST standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DETECTION_METHOD standard_relation:None standard_value:None standard_units:None comments:None | standard_type:MEDIA standard_relation:None standard_value:None standard_units:None comments:None | standard_type:PLATE_TYPE standard_relation:None standard_value:None standard_units:None comments:None | standard_type:TIME standard_relation:= standard_value:18.0 standard_units:hr comments:None";"";"";"";"";""
"CHEMBL3215270";"F";"PubChem BioAssay. qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS.   (Class of assay: confirmatory) ";"";"22759";"22913";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4495582";"F";"SARS-CoV-2 3CL-Pro protease inhibition percentage at 20M  by FRET kind of response from peptide substrate";"Severe acute respiratory syndrome coronavirus 2";"7218";"8702";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"SARS-CoV-2 Screening Data 2020-21";"2697049";"";"";"";"";"CHEMBL4495564";"None";"10.6019/CHEMBL4495564";"2020";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4005406";"F";"Antiproliferative activity against human SKM1-R cells after 48 hrs by XTT assay";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"SKM1-R";"";"CHEMBL4004814";"28094938";"10.1021/acs.jmedchem.6b01803";"2017";"J Med Chem";"60";"1523";"1533";"";"";"";"";"";""
"CHEMBL4005437";"F";"Antiproliferative activity against human SKM1-R cells after 48 hrs by DAPI-staining-based flow cytometric method";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"SKM1-R";"";"CHEMBL4004814";"28094938";"10.1021/acs.jmedchem.6b01803";"2017";"J Med Chem";"60";"1523";"1533";"";"";"";"";"";""
"CHEMBL981350";"F";"Antiproliferative activity against mouse P388 cells after 48 hrs by MTT assay";"Mus musculus";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1147285";"2778449";"10.1021/np50063a010";"1989";"J Nat Prod";"52";"522";"527";"";"";"";"";"";""
"CHEMBL981351";"F";"Antiproliferative activity against mouse P388 cells at 1 ug after 48 hrs by two-layer agar-diffusion method";"Mus musculus";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1147285";"2778449";"10.1021/np50063a010";"1989";"J Nat Prod";"52";"522";"527";"";"";"";"";"";""
"CHEMBL3137739";"T";"Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL1266185";"F";"Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay";"Mus musculus";"1252";"1259";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1255231";"17417631";"10.1038/nchembio873";"2007";"Nat Chem Biol";"3";"268";"273";"";"";"";"";"";""
"CHEMBL1794376";"F";"PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of vitamin D receptor signaling. (Class of assay: confirmatory) ";"";"205";"235";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1794382";"F";"PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of glucocorticoid receptor signaling. (Class of assay: confirmatory) ";"";"332";"385";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4296189";"F";"Antifungal activity against Candida albicans ATCC 90028 (CO-ADD:FG_001); MIC in YNB media using NBS plates, by OD630";"Candida albicans";"6134";"6236";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"ATCC 90028";"CO-ADD antimicrobial screening data";"5476";"";"";"";"";"CHEMBL4296181";"None";"10.6019/CHEMBL4296181";"None";"None";"None";"None";"None";"standard_type:ASSAY_TEST standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DETECTION_METHOD standard_relation:None standard_value:None standard_units:None comments:None | standard_type:MEDIA standard_relation:None standard_value:None standard_units:None comments:None | standard_type:PLATE_TYPE standard_relation:None standard_value:None standard_units:None comments:None | standard_type:TIME standard_relation:= standard_value:18.0 standard_units:hr comments:None";"";"";"";"";""
"CHEMBL3215086";"F";"PubChem BioAssay. qHTS profiling for inhibitors of Plasmodium falciparum (HB3) proliferation.   (Class of assay: confirmatory) ";"";"200";"206";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3214791";"F";"PubChem BioAssay. qHTS for Activators of Parkin Expression:  LOPAC Validation Assay (NLuc Reporter).   (Class of assay: confirmatory) ";"";"63";"63";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3562119";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 green channel.   (Class of assay: confirmatory) ";"";"2170";"2186";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3088861";"F";"Antiviral activity against HIV1 assessed as viral infection";"Human immunodeficiency virus 1";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"11676";"";"";"";"";"CHEMBL3085671";"24120088";"10.1016/j.bmc.2013.08.023";"2013";"Bioorg Med Chem";"21";"7222";"7228";"";"";"";"";"";""
"CHEMBL3801911";"F";"Antiviral activity against VSV-G pseudotyped HIV-1 NL4-3 infected in human U373-MAGI cells assessed as increase in frequency of G to C transversion at 260 uM incubated for 2 hrs prior to infection measured at 72 hrs post infection by illumina sequencing method relative to control";"Human immunodeficiency virus 1";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"NL4-3";"Scientific Literature";"11676";"";"";"U373-MAGI";"";"CHEMBL3797079";"27117260";"10.1016/j.bmc.2016.03.052";"2016";"Bioorg Med Chem";"24";"2410";"2422";"";"";"";"";"";""
"CHEMBL3562064";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, blue channel.   (Class of assay: confirmatory) ";"";"1996";"2013";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2354254";"F";"PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT. (Class of assay: confirmatory) ";"";"153871";"156311";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3137733";"T";"Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137728";"T";"Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137724";"T";"Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is number of references indexed. [column 'AIGUE' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137722";"T";"Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3802576";"F";"Antiviral activity against VSV-G pseudotyped HIV-1 NL4-3 infected in human U373-MAGI cells assessed as Gag mutation at 260 uM incubated for 2 hrs prior to infection measured at 72 hrs post infection by illumina sequencing method (Rvb = 18.4%)";"Human immunodeficiency virus 1";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"NL4-3";"Scientific Literature";"11676";"";"";"U373-MAGI";"";"CHEMBL3797079";"27117260";"10.1016/j.bmc.2016.03.052";"2016";"Bioorg Med Chem";"24";"2410";"2422";"";"";"";"";"";""
"CHEMBL3214929";"F";"PubChem BioAssay. Luminescence cell-based Retest at Dose assay to determine EWS/Fli1 dependent TC71 mammalian cell cytotoxity  Measured in Cell-Based System Using Plate Reader - 7014-04_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ";"";"637";"640";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3137723";"T";"Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137734";"T";"Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3562027";"F";"PubChem BioAssay. HCT116 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ";"";"232";"232";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3562123";"F";"PubChem BioAssay. HT-29 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ";"";"228";"229";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3284454";"F";"Antitumor activity against mouse L1210 cells allografted in ip dosed mouse assessed as dose required for maximal activity administered qd from day 1 to day 9 post tumor implantation";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL4005424";"F";"Antiproliferative activity against human SKM1-S cells after 48 hrs by DAPI-staining-based flow cytometric method";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"SKM1-S";"";"CHEMBL4004814";"28094938";"10.1021/acs.jmedchem.6b01803";"2017";"J Med Chem";"60";"1523";"1533";"";"";"";"";"";""
"CHEMBL3284452";"F";"Antitumor activity against mouse L1210 cells allografted in ip dosed mouse assessed as dose required for maximal activity administered qd on day 1, 5 and 9 post tumor implantation";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3562124";"F";"PubChem BioAssay. DLD-1 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ";"";"231";"231";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4137466";"B";"Inhibition of human G9a using biotinylated-H3K9 peptide as substrate after 1 hr in presence of SAM by TR-FRET assay";"Homo sapiens";"39";"39";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4130634";"29953809";"10.1021/acs.jmedchem.7b01926";"2018";"J Med Chem";"61";"6518";"6545";"";"";"";"";"";""
"CHEMBL4266416";"F";"Growth inhibition of human KB cells";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL4265876";"29135244";"10.1021/acs.jnatprod.7b00575";"2017";"J Nat Prod";"80";"3060";"3079";"";"";"";"";"";""
"CHEMBL3256552";"F";"Antitumor activity in mouse L1210 cells allografted in CDF1 mouse assessed as increase in life span at 3.12 mg/kg, ip administered as qd for 9 days relative to control";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244095";"92567";"10.1021/jm00196a015";"1979";"J Med Chem";"22";"1230";"1234";"standard_type:DOSE standard_relation:= standard_value:3.12 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3257015";"P";"Drug degradation in water solution at 25 degC after 5.5 hrs by reverse phase liquid chromatography";"";"1";"1";"BAO_0000100";"small-molecule physicochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL3244095";"92567";"10.1021/jm00196a015";"1979";"J Med Chem";"22";"1230";"1234";"";"";"";"";"";""
"CHEMBL3784461";"B";"Inhibition of UHRF1 in human MCF7 cells assessed as reduction in global 5-methylcytosine level at 15 uM after 72 hrs by HPLC-MS/MS analysis relative to control";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL3779829";"27049577";"10.1016/j.ejmech.2016.02.043";"2016";"Eur J Med Chem";"114";"390";"396";"";"";"";"";"";""
"CHEMBL3257345";"A";"Drug excretion in New Zealand white rabbit urine assessed as NSC-102816 equivalent excretion at 15 mg/kg, iv after 8 hrs by liquid scintillation counting";"Oryctolagus cuniculus";"2";"2";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"New Zealand white";"Scientific Literature";"9986";"CHEMBL3638201";"Urine";"";"";"CHEMBL3244184";"66316";"10.1021/jm00214a034";"1977";"J Med Chem";"20";"598";"600";"standard_type:DOSE standard_relation:= standard_value:15.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL4137467";"B";"Inhibition of human DNMT1 using polydeoxyinosine polydeoxycytosine DNA as substrate after 15 mins in presence of SAM by TR-FRET assay";"Homo sapiens";"39";"39";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4130634";"29953809";"10.1021/acs.jmedchem.7b01926";"2018";"J Med Chem";"61";"6518";"6545";"";"";"";"";"";""
"CHEMBL3562136";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 blue channel.   (Class of assay: confirmatory) ";"";"1968";"1982";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3255789";"T";"Toxicity in mouse L1210 cells allografted CDF1 mouse assessed as change in body weight between day 1 and day 5 at 20 mg/kg, ip dosed on days 1 and 5";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"CDF1";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244387";"74412";"10.1021/jm00200a012";"1978";"J Med Chem";"21";"204";"208";"standard_type:DOSE standard_relation:= standard_value:20.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL3255782";"F";"Antitumor activity against mouse L1210 cells allografted in CDF1 mouse assessed as increase in life span at 40 mg/kg, ip relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244387";"74412";"10.1021/jm00200a012";"1978";"J Med Chem";"21";"204";"208";"standard_type:DOSE standard_relation:= standard_value:40.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3285521";"F";"Antitumor activity against mouse L1210 cells allografted in po dosed mouse assessed as change in body weight at optimal dose administered qd from day 1 to day 9 post tumor implantation measured on day 5 relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL4005427";"F";"Induction of apoptosis in human SKM1-S cells assessed as caspase 3 cleavage at 1 uM by Western blot method";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"SKM1-S";"";"CHEMBL4004814";"28094938";"10.1021/acs.jmedchem.6b01803";"2017";"J Med Chem";"60";"1523";"1533";"";"";"";"";"";""
"CHEMBL2354221";"F";"PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT. (Class of assay: confirmatory) ";"";"172535";"175189";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3784457";"B";"Inhibition of UHRF1 in human MCF7 cells assessed as decrease in methylation at RAR beta exon at 15 uM after 72 hrs by methylation specific-PCR method";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL3779829";"27049577";"10.1016/j.ejmech.2016.02.043";"2016";"Eur J Med Chem";"114";"390";"396";"";"";"";"";"";""
"CHEMBL2354211";"F";"PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line. (Class of assay: confirmatory) ";"";"35070";"35135";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3255786";"F";"Antitumor activity against mouse L1210 cells allografted in CDF1 mouse assessed as increase in life span at 2.5 mg/kg, ip relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244387";"74412";"10.1021/jm00200a012";"1978";"J Med Chem";"21";"204";"208";"standard_type:DOSE standard_relation:= standard_value:2.5 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3255783";"F";"Antitumor activity against mouse L1210 cells allografted in CDF1 mouse assessed as increase in life span at 20 mg/kg, ip relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244387";"74412";"10.1021/jm00200a012";"1978";"J Med Chem";"21";"204";"208";"standard_type:DOSE standard_relation:= standard_value:20.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3418016";"A";"Half life in sc dosed patient with myelodysplastic syndrome";"Homo sapiens";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3414469";"25406944";"10.1021/jm500843d";"2015";"J Med Chem";"58";"2569";"2583";"";"";"";"";"";""
"CHEMBL3562024";"F";"PubChem BioAssay. VEGF stimulated ADSC/ECFC co-culture nuclear area decrease (viability)-IC50.   (Class of assay: confirmatory) ";"";"369";"370";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3255788";"T";"Toxicity in mouse L1210 cells allografted CDF1 mouse assessed as change in body weight between day 1 and day 5 at 40 mg/kg, ip dosed on days 1 and 5";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"CDF1";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244387";"74412";"10.1021/jm00200a012";"1978";"J Med Chem";"21";"204";"208";"standard_type:DOSE standard_relation:= standard_value:40.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL4303805";"F";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging";"Homo sapiens";"5616";"5632";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"SARS-CoV-2 Screening Data 2020-21";"9606";"";"";"Caco-2";"";"CHEMBL4303101";"None";"10.21203/rs.3.rs-23951/v1";"2020";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3255792";"T";"Toxicity in mouse L1210 cells allografted CDF1 mouse assessed as change in body weight between day 1 and day 5 at 2.5 mg/kg, ip dosed on days 1 and 5";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"CDF1";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244387";"74412";"10.1021/jm00200a012";"1978";"J Med Chem";"21";"204";"208";"standard_type:DOSE standard_relation:= standard_value:2.5 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL3284440";"F";"Antitumor activity against mouse P388 cells allografted in ip dosed mouse assessed as dose required for minimal activity administered qd from day 1 to day 9 post tumor implantation";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3284451";"F";"Antitumor activity against mouse L1210 cells allografted in ip dosed mouse assessed as dose required for maximal activity administered qd on day 1 post tumor implantation";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3285526";"P";"Drug degradation in lactated Ringer's solution at 25 degC after 4.7 hrs";"";"1";"1";"BAO_0000100";"small-molecule physicochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"";"";"";"";""
"CHEMBL3802548";"F";"Antiviral activity against VSV-G pseudotyped HIV-1 NL4-3 infected in human U373-MAGI cells assessed as increase in mutation frequency at 260 uM incubated for 2 hrs prior to infection measured at 72 hrs post infection by illumina sequencing method";"Human immunodeficiency virus 1";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"NL4-3";"Scientific Literature";"11676";"";"";"U373-MAGI";"";"CHEMBL3797079";"27117260";"10.1016/j.bmc.2016.03.052";"2016";"Bioorg Med Chem";"24";"2410";"2422";"";"";"";"";"";""
"CHEMBL3802579";"F";"Antiviral activity against VSV-G pseudotyped HIV-1 NL4-3 infected in human U373-MAGI cells assessed as Env mutation at 260 uM incubated for 2 hrs prior to infection measured at 72 hrs post infection by illumina sequencing method (Rvb = 21.4%)";"Human immunodeficiency virus 1";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"NL4-3";"Scientific Literature";"11676";"";"";"U373-MAGI";"";"CHEMBL3797079";"27117260";"10.1016/j.bmc.2016.03.052";"2016";"Bioorg Med Chem";"24";"2410";"2422";"";"";"";"";"";""
"CHEMBL3256218";"T";"Toxicity in mouse L1210 cells allografted CDF1 mouse assessed as mortality at 2.5 to 40 mg/kg, ip";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"CDF1";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244387";"74412";"10.1021/jm00200a012";"1978";"J Med Chem";"21";"204";"208";"standard_type:DOSE standard_relation:None standard_value:None standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL3284448";"T";"Toxicity in ip dosed mouse allografted with mouse L1210 cells assessed as dose required for optimal activity administered qd from day 1 to day 9 post intracerebral tumor implantation";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3284436";"F";"Antitumor activity against mouse L1210 cells allografted in ip dosed mouse assessed as dose required for minimal activity administered every 6 hrs on day 1, 5 and 9 post tumor implantation";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3284441";"F";"Antitumor activity against mouse B16 cells allografted in ip dosed mouse assessed as dose required for minimal activity administered qd from day 1 to day 9 post tumor implantation";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL4005428";"F";"Induction of apoptosis in human SKM1-R cells assessed as caspase 3 cleavage at 10 uM by Western blot method";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"SKM1-R";"";"CHEMBL4004814";"28094938";"10.1021/acs.jmedchem.6b01803";"2017";"J Med Chem";"60";"1523";"1533";"";"";"";"";"";""
"CHEMBL3284165";"F";"Antitumor activity against mouse B16 cells allografted in ip dosed mouse assessed as increase in life span at optimal dose administered qd from day 1 to day 9 post tumor implantation relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3255797";"T";"Toxicity in mouse L1210 cells allografted CDF1 mouse assessed as change in body weight between day 1 and day 9 at 2.5 mg/kg, ip dosed on days 1, 5 and 9";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"CDF1";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244387";"74412";"10.1021/jm00200a012";"1978";"J Med Chem";"21";"204";"208";"standard_type:DOSE standard_relation:= standard_value:2.5 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL3255791";"T";"Toxicity in mouse L1210 cells allografted CDF1 mouse assessed as change in body weight between day 1 and day 5 at 5 mg/kg, ip dosed on days 1 and 5";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"CDF1";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244387";"74412";"10.1021/jm00200a012";"1978";"J Med Chem";"21";"204";"208";"standard_type:DOSE standard_relation:= standard_value:5.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL3802578";"F";"Antiviral activity against VSV-G pseudotyped HIV-1 NL4-3 infected in human U373-MAGI cells assessed as Vif mutation at 260 uM incubated for 2 hrs prior to infection measured at 72 hrs post infection by illumina sequencing method (Rvb = 19.2%)";"Human immunodeficiency virus 1";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"NL4-3";"Scientific Literature";"11676";"";"";"U373-MAGI";"";"CHEMBL3797079";"27117260";"10.1016/j.bmc.2016.03.052";"2016";"Bioorg Med Chem";"24";"2410";"2422";"";"";"";"";"";""
"CHEMBL3255793";"T";"Toxicity in mouse L1210 cells allografted CDF1 mouse assessed as change in body weight between day 1 and day 9 at 40 mg/kg, ip dosed on days 1, 5 and 9";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"CDF1";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244387";"74412";"10.1021/jm00200a012";"1978";"J Med Chem";"21";"204";"208";"standard_type:DOSE standard_relation:= standard_value:40.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL4651403";"F";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"Chlorocebus sabaeus";"4309";"8710";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"IMI-CARE SARS-CoV-2 Data";"60711";"";"";"Vero C1008";"";"CHEMBL4651402";"None";"10.6019/CHEMBL4651402";"2021";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4046838";"P";"Partition coefficient, log P of the compound";"";"2";"2";"BAO_0000100";"small-molecule physicochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL4043202";"28843845";"10.1016/j.bmc.2017.08.011";"2017";"Bioorg Med Chem";"25";"5513";"5521";"";"";"";"";"";""
"CHEMBL5096928";"F";"Inhibition of HIV-1 latency infected in human ACH-2 cells assessed as fold increase in HIV production by measuring p24 level incubated for 48 hrs in presence of BIX01294 by ELISA";"Human immunodeficiency virus 1";"2";"2";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"11676";"";"";"ACH-2 cell line";"";"CHEMBL5096158";"33540228";"10.1016/j.ejmech.2021.113213";"2021";"Eur J Med Chem";"213";"113213";"113213";"";"";"";"";"";""
"CHEMBL2114842";"F";"PubChem BioAssay. qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway. (Class of assay: confirmatory) ";"Homo sapiens";"512";"532";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2114877";"F";"PubChem BioAssay. qHTS screen for small molecules that inhibit ELG1-dependent DNA repair: Hit Confirmation with MMS Viability. (Class of assay: confirmatory) ";"Homo sapiens";"385";"385";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3562002";"F";"PubChem BioAssay. Immunotoxin (HA22) sensitization/mitigation study. Vehicle arm (PBS).   (Class of assay: confirmatory) ";"";"370";"372";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3562135";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 blue channel.   (Class of assay: confirmatory) ";"";"556";"556";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4296188";"F";"Antibacterial activity against Acinetobacter baumannii ATCC 19606 (CO-ADD:GN_034); MIC in CAMBH media using NBS plates, by OD600";"Acinetobacter baumannii";"22588";"22685";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"ATCC 19606";"CO-ADD antimicrobial screening data";"470";"";"";"";"";"CHEMBL4296181";"None";"10.6019/CHEMBL4296181";"None";"None";"None";"None";"None";"standard_type:ASSAY_TEST standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DETECTION_METHOD standard_relation:None standard_value:None standard_units:None comments:None | standard_type:MEDIA standard_relation:None standard_value:None standard_units:None comments:None | standard_type:PLATE_TYPE standard_relation:None standard_value:None standard_units:None comments:None | standard_type:TIME standard_relation:= standard_value:18.0 standard_units:hr comments:None";"";"";"";"";""
"CHEMBL3284437";"F";"Antitumor activity against mouse L1210 cells allografted in ip dosed mouse assessed as dose required for minimal activity administered qd from day 1 to day 9 post tumor implantation";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3257008";"T";"Toxicity in CDF1 mouse assessed as change in body weight at 12.5 mg/kg, ip measured on day 5 relative to control";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"CDF1";"Scientific Literature";"10090";"";"";"";"";"CHEMBL3244095";"92567";"10.1021/jm00196a015";"1979";"J Med Chem";"22";"1230";"1234";"standard_type:DOSE standard_relation:= standard_value:12.5 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL3284456";"F";"Antitumor activity against mouse L1210 cells allografted in ip dosed mouse assessed as dose required for maximal activity administered qd from day 1 to day 9 post intracerebral tumor implantation";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3257013";"T";"Toxicity in CDF1 mouse assessed as change in body weight at 1.56 mg/kg, ip measured on day 5 relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"CDF1";"Scientific Literature";"10090";"";"";"";"";"CHEMBL3244095";"92567";"10.1021/jm00196a015";"1979";"J Med Chem";"22";"1230";"1234";"standard_type:DOSE standard_relation:= standard_value:1.56 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL3255795";"T";"Toxicity in mouse L1210 cells allografted CDF1 mouse assessed as change in body weight between day 1 and day 9 at 10 mg/kg, ip dosed on days 1, 5 and 9";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"CDF1";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244387";"74412";"10.1021/jm00200a012";"1978";"J Med Chem";"21";"204";"208";"standard_type:DOSE standard_relation:= standard_value:10.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL3285523";"F";"Antitumor activity against mouse L1210 cells allografted in ip dosed mouse assessed as change in body weight at optimal dose administered every 6 hrs on day 1, 5 and 9 post tumor implantation measured on day 5 relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3284458";"P";"Drug degradation in 1 N ammonium hydroxide solution assessed as l-beta-D-Ribofuranosyl-3-guanylurea level";"";"1";"1";"BAO_0000100";"small-molecule physicochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"";"";"";"";""
"CHEMBL3802580";"F";"Antiviral activity against VSV-G pseudotyped HIV-1 NL4-3 infected in human U373-MAGI cells assessed as Nef mutation at 260 uM incubated for 2 hrs prior to infection measured at 72 hrs post infection by illumina sequencing method (Rvb = 22.6%)";"Human immunodeficiency virus 1";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"NL4-3";"Scientific Literature";"11676";"";"";"U373-MAGI";"";"CHEMBL3797079";"27117260";"10.1016/j.bmc.2016.03.052";"2016";"Bioorg Med Chem";"24";"2410";"2422";"";"";"";"";"";""
"CHEMBL3784458";"B";"Inhibition of UHRF1 in human MCF7 cells assessed as DNA global demethylation by measuring 5-methylcytosine level at 15 uM after 72 hrs by HPLC-MS/MS analysis (Rvb = 1.7 +/- 0.36%)";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL3779829";"27049577";"10.1016/j.ejmech.2016.02.043";"2016";"Eur J Med Chem";"114";"390";"396";"";"";"";"";"";""
"CHEMBL3215017";"F";"PubChem BioAssay. qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS.   (Class of assay: confirmatory) ";"";"26950";"27095";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4513082";"F";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"Chlorocebus sabaeus";"7218";"17404";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"SARS-CoV-2 Screening Data 2020-21";"60711";"";"";"Vero C1008";"";"CHEMBL4495565";"None";"10.6019/CHEMBL4495565";"2020";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3256553";"F";"Antitumor activity in mouse L1210 cells allografted in CDF1 mouse assessed as increase in life span at 1.56 mg/kg, ip administered as qd for 9 days relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244095";"92567";"10.1021/jm00196a015";"1979";"J Med Chem";"22";"1230";"1234";"standard_type:DOSE standard_relation:= standard_value:1.56 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3284443";"T";"Toxicity in ip dosed mouse allografted with mouse L1210 cells assessed as dose required for optimal activity administered qd on day 1, 5 and 9 post tumor implantation";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3284455";"F";"Antitumor activity against mouse L1210 cells allografted in po dosed mouse assessed as dose required for maximal activity administered qd from day 1 to day 9 post tumor implantation";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3137732";"T";"Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137726";"T";"Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL2320305";"B";"Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells at 20 uM after 1.5 mins by fluorescence assay";"Homo sapiens";"46";"46";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"HEK293";"";"CHEMBL2311273";"23241029";"10.1021/jm301302s";"2013";"J Med Chem";"56";"781";"795";"";"";"";"";"";""
"CHEMBL3285528";"F";"Antitumor activity against mouse L1210 cells allografted in ip dosed mouse assessed as increase in life span at optimal dose administered qd on day 1, 5 and 9 post tumor implantation relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3284167";"F";"Antitumor activity against mouse L1210 cells allografted in ip dosed mouse assessed as dose required for minimal activity administered qd on day 1, 5 and 9 post tumor implantation";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3802549";"F";"Antiviral activity against VSV-G pseudotyped HIV-1 NL4-3 infected in human U373-MAGI cells assessed as G to C transversion at 260 uM incubated for 2 hrs prior to infection measured at 72 hrs post infection by illumina sequencing method relative to control";"Human immunodeficiency virus 1";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"NL4-3";"Scientific Literature";"11676";"";"";"U373-MAGI";"";"CHEMBL3797079";"27117260";"10.1016/j.bmc.2016.03.052";"2016";"Bioorg Med Chem";"24";"2410";"2422";"";"";"";"";"";""
"CHEMBL3256554";"F";"Antitumor activity in mouse L1210 cells allografted in CDF1 mouse assessed as increase in life span at 0.78 mg/kg, ip administered as qd for 9 days relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244095";"92567";"10.1021/jm00196a015";"1979";"J Med Chem";"22";"1230";"1234";"standard_type:DOSE standard_relation:= standard_value:0.78 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3257014";"T";"Toxicity in CDF1 mouse assessed as change in body weight at 0.78 mg/kg, ip measured on day 5 relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"CDF1";"Scientific Literature";"10090";"";"";"";"";"CHEMBL3244095";"92567";"10.1021/jm00196a015";"1979";"J Med Chem";"22";"1230";"1234";"standard_type:DOSE standard_relation:= standard_value:0.78 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL3562043";"F";"PubChem BioAssay. VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-IC50.   (Class of assay: confirmatory) ";"";"368";"369";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4296186";"F";"Antibacterial activity against Klebsiella pneumoniae MDR ATCC 70063 (CO-ADD:GN_003); MIC in CAMBH media using NBS plates, by OD(600)";"Klebsiella pneumoniae";"6160";"6262";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"ATCC 700603";"CO-ADD antimicrobial screening data";"573";"";"";"";"";"CHEMBL4296181";"None";"10.6019/CHEMBL4296181";"None";"None";"None";"None";"None";"standard_type:ASSAY_TEST standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DETECTION_METHOD standard_relation:None standard_value:None standard_units:None comments:None | standard_type:MEDIA standard_relation:None standard_value:None standard_units:None comments:None | standard_type:PLATE_TYPE standard_relation:None standard_value:None standard_units:None comments:None | standard_type:TIME standard_relation:= standard_value:18.0 standard_units:hr comments:None";"";"";"";"";""
"CHEMBL3215169";"B";"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) ";"";"3383";"3728";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3137735";"T";"Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137740";"T";"Proposed mechanism(s) of liver damage. [column 'MEC' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137730";"T";"Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137737";"T";"Presence of at least one case with successful reintroduction. [column 'REINT' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137725";"T";"Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3134963";"B";"Inhibition of DNMT in human MDA-MB-231 cells assessed as reduction in methylation level at 1 uM by luminometric methylation assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"MDA-MB-231";"";"CHEMBL3132825";"None";"10.1039/C3MD00214D";"2013";"Medchemcomm";"4";"1562";"1570";"";"";"";"";"";""
"CHEMBL3257346";"A";"Drug excretion in New Zealand white rabbit bile assessed as unchanged NSC-102816 excretion at 15 mg/kg, iv after 8 hrs by TLC/liquid scintillation counting";"Oryctolagus cuniculus";"2";"2";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"New Zealand white";"Scientific Literature";"9986";"CHEMBL3638228";"Bile";"";"";"CHEMBL3244184";"66316";"10.1021/jm00214a034";"1977";"J Med Chem";"20";"598";"600";"standard_type:DOSE standard_relation:= standard_value:15.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL3255785";"F";"Antitumor activity against mouse L1210 cells allografted in CDF1 mouse assessed as increase in life span at 5 mg/kg, ip relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244387";"74412";"10.1021/jm00200a012";"1978";"J Med Chem";"21";"204";"208";"standard_type:DOSE standard_relation:= standard_value:5.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3804213";"F";"Antiviral activity against VSV-G pseudotyped HIV-1 NL4-3 infected in human U373-MAGI cells assessed as C to G transversion at 260 uM incubated for 2 hrs prior to infection measured at 72 hrs post infection by illumina sequencing method relative to control";"Human immunodeficiency virus 1";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"NL4-3";"Scientific Literature";"11676";"";"";"U373-MAGI";"";"CHEMBL3797079";"27117260";"10.1016/j.bmc.2016.03.052";"2016";"Bioorg Med Chem";"24";"2410";"2422";"";"";"";"";"";""
"CHEMBL3285518";"F";"Antitumor activity against mouse B16 cells allografted in ip dosed mouse assessed as change in body weight at optimal dose administered qd from day 1 to day 9 post tumor implantation measured on day 5 relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL4020299";"T";"Toxicity in NOD.SCID mouse assessed as maximum mean body weight loss at 8 mg/kg, iv qd for every 7 days (Rvb = 9%)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL4017535";"28949521";"10.1021/acs.jmedchem.7b00746";"2017";"J Med Chem";"60";"8369";"8384";"";"ALIMENTARY TRACT AND METABOLISM | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Genetically Diabetic Animals | Methods for Testing Immunological Factors";"Spontaneously Diabetic Mice: KK Mouse, KK-AY Mouse, NOD Mouse, Obese Hyperglycemic Mice, Diabetic db/db Mice, Diabetes Obesity Syndrome in CBA/Ca Mice, Wellesley Mouse | Spontaneous Autoimmune Diseases In Animals";"";""
"CHEMBL3863231";"B";"Displacement of [3H]rosiglitazone from recombinant human C-terminal His-tagged MitoNEET cytosolic domain (32 to 108 residues) expressed in Escherichia coli BL21 by Cheng-Prusoff analysis";"Homo sapiens";"86";"86";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3862005";"27687671";"10.1016/j.bmcl.2016.09.009";"2016";"Bioorg Med Chem Lett";"26";"5350";"5353";"";"";"";"";"";""
"CHEMBL3802124";"F";"Reduction in dCTP level in human U373-MAGI cells at EC75 after 4 hrs by LC-MS/MS analysis relative to control";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"U373-MAGI";"";"CHEMBL3797079";"27117260";"10.1016/j.bmc.2016.03.052";"2016";"Bioorg Med Chem";"24";"2410";"2422";"";"";"";"";"";""
"CHEMBL3285516";"P";"Half life of the compound at 25 degC at pH 7 by HPLC analysis";"";"1";"1";"BAO_0000100";"small-molecule physicochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"";"";"";"";""
"CHEMBL3863230";"B";"Displacement of [3H]rosiglitazone from recombinant human C-terminal His-tagged MitoNEET cytosolic domain (32 to 108 residues) expressed in Escherichia coli BL21 by scintillation proximity assay";"Homo sapiens";"86";"86";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3862005";"27687671";"10.1016/j.bmcl.2016.09.009";"2016";"Bioorg Med Chem Lett";"26";"5350";"5353";"";"";"";"";"";""
"CHEMBL3285527";"F";"Antitumor activity against mouse L1210 cells allografted in ip dosed mouse assessed as increase in life span at optimal dose administered qd on day 1 post tumor implantation relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL4046837";"P";"Solubility in water";"";"2";"2";"BAO_0000100";"small-molecule physicochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL4043202";"28843845";"10.1016/j.bmc.2017.08.011";"2017";"Bioorg Med Chem";"25";"5513";"5521";"";"";"";"";"";""
"CHEMBL3802568";"F";"Antiviral activity against VSV-G pseudotyped HIV-1 NL4-3 infected in human U373-MAGI cells assessed as reduction in gag level at 25 to 400 uM after 2 to 72 hrs by qPCR method";"Human immunodeficiency virus 1";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"NL4-3";"Scientific Literature";"11676";"";"";"U373-MAGI";"";"CHEMBL3797079";"27117260";"10.1016/j.bmc.2016.03.052";"2016";"Bioorg Med Chem";"24";"2410";"2422";"";"";"";"";"";""
"CHEMBL4266395";"F";"Antibacterial activity against Escherichia coli";"Escherichia coli";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"562";"";"";"";"";"CHEMBL4265876";"29135244";"10.1021/acs.jnatprod.7b00575";"2017";"J Nat Prod";"80";"3060";"3079";"";"";"";"";"";""
"CHEMBL3253664";"A";"Drug excretion in New Zealand white rabbit bile assessed as NSC-102816 equivalent excretion at 15 mg/kg, iv after 8 hrs by liquid scintillation counting";"Oryctolagus cuniculus";"2";"2";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"New Zealand white";"Scientific Literature";"9986";"CHEMBL3638228";"Bile";"";"";"CHEMBL3244184";"66316";"10.1021/jm00214a034";"1977";"J Med Chem";"20";"598";"600";"standard_type:DOSE standard_relation:= standard_value:15.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL3257347";"A";"Drug excretion in New Zealand white rabbit urine assessed as unchanged NSC-102816 excretion at 15 mg/kg, iv after 8 hrs by TLC/liquid scintillation counting";"Oryctolagus cuniculus";"2";"2";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"New Zealand white";"Scientific Literature";"9986";"CHEMBL3638201";"Urine";"";"";"CHEMBL3244184";"66316";"10.1021/jm00214a034";"1977";"J Med Chem";"20";"598";"600";"standard_type:DOSE standard_relation:= standard_value:15.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL3562034";"F";"PubChem BioAssay. Immunotoxin (SS1P) sensitization/mitigation study. Vehicle arm (DMEM).   (Class of assay: confirmatory) ";"";"344";"346";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3284159";"F";"Antitumor activity against mouse L1210 cells allografted in ip dosed mouse assessed as increase in life span at optimal dose administered every 6 hrs on day 1, 5 and 9 post tumor implantation relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3284445";"T";"Toxicity in ip dosed mouse allografted with mouse L1210 cells assessed as dose required for optimal activity administered qd from day 1 to day 9 post tumor implantation";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3284449";"T";"Toxicity in ip dosed mouse allografted with mouse P388 cells assessed as dose required for optimal activity administered qd from day 1 to day 9 post tumor implantation";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3562021";"F";"PubChem BioAssay. RKO viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ";"";"233";"234";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3561990";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, green channel.   (Class of assay: confirmatory) ";"";"2189";"2208";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3561973";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 ratio channel.   (Class of assay: confirmatory) ";"";"558";"558";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3215292";"F";"PubChem BioAssay. qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen.   (Class of assay: confirmatory) ";"";"235";"242";"BAO_0000019";"assay format";"3";"3 - Target assigned is molecular non-protein target";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3284164";"F";"Antitumor activity against mouse P388 cells allografted in ip dosed mouse assessed as increase in life span at optimal dose administered qd from day 1 to day 9 post tumor implantation relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3284442";"T";"Toxicity in ip dosed mouse allografted with mouse L1210 cells assessed as dose required for optimal activity administered qd on day 1 post tumor implantation";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3284450";"T";"Toxicity in ip dosed mouse allografted with mouse B16 cells assessed as dose required for optimal activity administered qd from day 1 to day 9 post tumor implantation";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3285519";"F";"Antitumor activity against mouse P388 cells allografted in ip dosed mouse assessed as change in body weight at optimal dose administered qd from day 1 to day 9 post tumor implantation measured on day 5 relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3272089";"69026";"10.1021/jm00216a013";"1977";"J Med Chem";"20";"806";"812";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3562067";"F";"PubChem BioAssay. Immunotoxin (HA22) sensitization/mitigation study - treatment arm (low dose).   (Class of assay: confirmatory) ";"";"407";"409";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3561996";"F";"PubChem BioAssay. SW480 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ";"";"233";"233";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3562036";"F";"PubChem BioAssay. Immunotoxin (HA22) sensitization/mitigation study - treatment arm (High Dose).   (Class of assay: confirmatory) ";"";"120";"120";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3255784";"F";"Antitumor activity against mouse L1210 cells allografted in CDF1 mouse assessed as increase in life span at 10 mg/kg, ip relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244387";"74412";"10.1021/jm00200a012";"1978";"J Med Chem";"21";"204";"208";"standard_type:DOSE standard_relation:= standard_value:10.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3801912";"F";"Antiviral activity against VSV-G pseudotyped HIV-1 NL4-3 infected in human U373-MAGI cells assessed as increase in frequency of C to G transversion at 260 uM incubated for 2 hrs prior to infection measured at 72 hrs post infection by illumina sequencing method relative to control";"Human immunodeficiency virus 1";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"NL4-3";"Scientific Literature";"11676";"";"";"U373-MAGI";"";"CHEMBL3797079";"27117260";"10.1016/j.bmc.2016.03.052";"2016";"Bioorg Med Chem";"24";"2410";"2422";"";"";"";"";"";""
